This suggests that Bmi‐1 overexpression in patients with GBM might be a result of c‐Myc activation, which in turn cooperates with the c‐Myc oncogene to promote tumorigenesis and maintain key properties of GBM cells [43]. This evidence concerns the gene MYC and glioblastoma.